Literature DB >> 31558554

Ibrutinib and lenalidomide: when 1+1 = >2.

Jason Westin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31558554     DOI： 10.1182/blood.2019002237

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Rituximab, lenalidomide and BTK inhibitor as frontline treatment for elderly or unfit patients with diffuse large B-cell lymphoma: a real-world analysis of single center.

Authors:  Yanan Zhu; Xiang Zhang; Juying Wei; Chunmei Yang; Hongyan Tong; Wenyuan Mai; Min Yang; Jiejing Qian; Liping Mao; Haitao Meng; Jie Jin; Wenjuan Yu
Journal:  Exp Hematol Oncol       Date:  2022-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.